Medpace Holdings (MEDP) EBITDA Margin Growth (1y) (2016 - 2026)
Medpace Holdings (MEDP) EBITDA Margin Growth (1y) (2016 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA Margin Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 213.44 Bn | 209.37 Bn | 8.34 Bn | 50.00 |
| 2 | Danaher | 139.95 Bn | 135.60 Bn | 3.61 Bn | 519.00 |
| 3 | Idexx Laboratories | 46.16 Bn | 45.96 Bn | 779.09 Mn | 136.00 |
| 4 | Agilent Technologies | 39.67 Bn | 37.87 Bn | 990.00 Mn | 376.00 |
| 5 | Iqvia Holdings | 39.29 Bn | 37.21 Bn | 1.44 Bn | -101.00 |
| 6 | Natera | 38.61 Bn | 37.51 Bn | 696.04 Mn | 235.00 |
| 7 | Illumina | 29.99 Bn | 28.82 Bn | 770.00 Mn | 93.00 |
| 8 | Mettler Toledo International | 28.57 Bn | 28.51 Bn | 650.22 Mn | 352.00 |
| 9 | Quest Diagnostics | 26.17 Bn | 25.55 Bn | 1.03 Bn | -78.00 |
| 10 | Medpace Holdings | 16.56 Bn | 16.06 Bn | 201.64 Mn | -18.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -18.00 |
| Mar 31, 2026 | -30.00 |
| Dec 31, 2025 | -173.00 |
| Sep 30, 2025 | 44.00 |
| Jun 30, 2025 | 103.00 |
| Mar 31, 2025 | -4.00 |
| Dec 31, 2024 | 585.00 |
| Sep 30, 2024 | 381.00 |
| Jun 30, 2024 | 290.00 |
| Mar 31, 2024 | 50.00 |
| Dec 31, 2023 | -187.00 |
| Sep 30, 2023 | -304.00 |
| Jun 30, 2023 | -14.00 |
| Mar 31, 2023 | 46.00 |
| Dec 31, 2022 | 162.00 |
| Sep 30, 2022 | 211.00 |
| Jun 30, 2022 | 190.00 |
| Mar 31, 2022 | 109.00 |
| Dec 31, 2021 | -340.00 |
| Sep 30, 2021 | -198.00 |